Jakob Lindberg is the founder of Oncopeptides. Oncopeptides has raised $130M in total funding. Based in Stockholm, Sweden.
Jakob Lindberg was appointed CEO of Oncopeptides, a biotech company focused on therapies for hematological diseases, in November 2021. He previously served as CEO from 2011 to 2020 and was also the Chief Scientific Officer. Oncopeptides develops compounds using its proprietary peptide-drug conjugate (PDC) platform.
Full founder directory · Investor directory · Company funding database · Fundraising library